The South African strain of coronavirus has been confirmed in the greater Houston area, and experts say it could spread quickly. ABC13 sat down with the city of Houston's health authority to see how the variant can impact COVID-19 testing and the vaccine.
With more vaccine set to arrive over the coming weeks, and thousands lined up to get their first dose, Action 13 is taking a look at what you should and should not do before getting the vaccine.
Thousands of Texans are Not Showing up for COVID-19 Shot #2
Enter your number to get our free mobile app
While many Texans are seeking information on the COVID-19 vaccine being made available in their area, others are waiting patiently for a chance to register for treatment in places that are already vaccinating. Believe it or not, there are reportedly thousands of Texans who have changed their minds.
WFAA reports there are Texans who are scheduled to receive shot #2 of their COVID-19 vaccine who are not showing up for the treatment. Many in the medical field say this will leave residents unprotected and is slowing down the process. As many as 15 to 20 percent of Texans due for dose number two are not showing up, many are the age group who are 65 and older. Doctor s like those at City Hospital in Dallas say they are hearing about logistics issues. Some folks can t find a ride to the clinic, or their appointment is scheduled for a day that no longer works for said patients.
NYU Langone pulmonologist Dr. Qanta Ahmed provides insight on ‘Fox and Friends Weekend.’
Front-line essential workers and those ages 75 and older will be next in line to receive COVID-19 vaccines, according to new recommendations Sunday by the Centers for Disease Control and Prevention s Advisory Committee on Immunization Practices.
The committee voted 13-to-1 in favor of the recommendations, which will now go to CDC Director Dr. Robert Redfield for final approval.
Once the recommendations are accepted by Redfield, they are expected to be published in the CDC s Morbidity and Mortality Weekly report this week then shared as official CDC guidance.
The so-called Phase 1B group is estimated to include about 49 million people, or nearly 15% of Americans.